TickerFacts.

Pacira BioSciences, Inc. (PCRX): Long-Term Debt

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2015-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$372.19M
As of 2025-12-31
$363.12M
As of 2026-06-30
-18.6%
3-year compound annual growth
+13.6%
10-year compound annual growth
$689.47M2011-12-31: $25.58M2012-12-31: $25.19M2013-12-31: $98.96M2014-12-31: $103.10M2015-12-31: $104.04M2016-12-31: $108.74M2022-12-31: $689.47M2023-12-31: $522.44M2024-12-31: $585.32M2025-12-31: $372.19M$372.19M
2011-12-31 Long-Term Debt (USD) 2025-12-31
Period endedLong-Term DebtChange YoYSource filing
2025-12-31$372.19M-36.4%2026-02-26, Balance as of period end
2024-12-31$585.32M+12.0%2026-02-26, Balance as of period end
2023-12-31$522.44M-24.2%2025-02-27, Balance as of period end
2022-12-31$689.47Mn/a2024-02-29, Balance as of period end
No annual figure between 2016-12-31 and 2022-12-31.
2016-12-31$108.74M+4.5%2017-03-01, Balance as of period end
2015-12-31$104.04Mn/c2017-03-01, Balance as of period end
2014-12-31$103.10M+4.2%2016-02-25, Balance as of period end
2013-12-31$98.96M+292.8%2015-02-24, Balance as of period end
2012-12-31$25.19M-1.5%2014-02-25, Balance as of period end
2011-12-31$25.58Mn/a2013-03-07, Balance as of period end

Long-Term Debt at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedLong-Term DebtChange YoY
Pacira BioSciences, Inc. (PCRX)2025-12-31$372.19M-36.4%
Emergent BioSolutions Inc. (EBS)2025-12-31$589.70M-15.8%
Harmony Biosciences Holdings, Inc. (HRMY)2025-12-31$163.66M-8.7%
Opko Health, Inc. (OPK)2025-12-31$343.97M-21.3%
Insmed Inc (INSM)2025-12-31$546.77M-51.3%
Ionis Pharmaceuticals Inc (IONS)2025-12-31$1.81B+44.6%
Madrigal Pharmaceuticals, Inc. (MDGL)2025-12-31$339.88M+189.1%
HUTCHMED (China) Ltd (HCM)2025-12-31$93.16M+12.5%
BridgeBio Pharma, Inc. (BBIO)2025-12-31$2.01Bn/a

Compare PCRX, EBS, HRMY, OPK side by side · Screen every company in Pharmaceutical Preparations ↗